About
Prof. Ed Sturrock is a Professor in the Department of Integrative Biomedical Sciences (Head of Department 2015-2020) and a founding member of the Institute of Infectious Disease and Molecular Medicine (IDM) at UCT. He received his PhD from the University of Cape Town and postdoctoral fellowship at Harvard Medical School with Jim Riordan where he started his research on angiotensin-converting enzyme. Together with colleagues from the UK and USA, he founded AngioDesign Ltd, a spinout company that focuses on the rational design of enhanced next-generation drugs for proven cardiovascular disease targets, such as ACE and neprilysin.
Selected publications
1485676
{1485676:UNPMDK5G},{1485676:6K8PEHIE},{1485676:ELR2NQWJ},{1485676:VSV6QEWF},{1485676:H66JZAPA},{1485676:8MEIYWVS},{1485676:VUAZPUX3}
1
nature
50
date
1
487
https://biophysicsworkshop.co.za/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22UNPMDK5G%22%2C%22library%22%3A%7B%22id%22%3A1485676%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Acharya%20et%20al.%22%2C%22parsedDate%22%3A%222024-08-05%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EAcharya%2C%20K.%20R.%2C%20Gregory%2C%20K.%20S.%20%26amp%3B%20Sturrock%2C%20E.%20D.%20Advances%20in%20the%20structural%20basis%20for%20angiotensin-1%20converting%20enzyme%20%28ACE%29%20inhibitors.%20%3Ci%3EBioscience%20Reports%3C%5C%2Fi%3E%20%3Cb%3E44%3C%5C%2Fb%3E%2C%20BSR20240130%20%282024%29.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fbiophysicsworkshop.co.za%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D1485676%26amp%3Bitem_key%3DUNPMDK5G%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Advances%20in%20the%20structural%20basis%20for%20angiotensin-1%20converting%20enzyme%20%28ACE%29%20inhibitors%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%5Cu00a0Ravi%22%2C%22lastName%22%3A%22Acharya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kyle%5Cu00a0S.%22%2C%22lastName%22%3A%22Gregory%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edward%5Cu00a0D.%22%2C%22lastName%22%3A%22Sturrock%22%7D%5D%2C%22abstractNote%22%3A%22Human%20somatic%20angiotensin-converting%20enzyme%20%28ACE%29%20is%20a%20key%20zinc%20metallopeptidase%20that%20plays%20a%20pivotal%20role%20in%20the%20renin%5Cu2013angiotensin%5Cu2013aldosterone%20system%20%28RAAS%29%20by%20regulating%20blood%20pressure%20and%20electrolyte%20balance.%20Inhibition%20of%20ACE%20is%20a%20cornerstone%20in%20the%20management%20of%20hypertension%2C%20cardiovascular%20diseases%2C%20and%20renal%20disorders.%20Recent%20advances%20in%20structural%20biology%20techniques%20have%20provided%20invaluable%20insights%20into%20the%20molecular%20mechanisms%20underlying%20ACE%20inhibition%2C%20facilitating%20the%20design%20and%20development%20of%20more%20effective%20therapeutic%20agents.%20This%20review%20focuses%20on%20the%20latest%20advancements%20in%20elucidating%20the%20structural%20basis%20for%20ACE%20inhibition.%20High-resolution%20crystallographic%20studies%20of%20minimally%20glycosylated%20individual%20domains%20of%20ACE%20have%20revealed%20intricate%20molecular%20details%20of%20the%20ACE%20catalytic%20N-%20and%20C-domains%2C%20and%20their%20detailed%20interactions%20with%20clinically%20relevant%20and%20newly%20designed%20domain-specific%20inhibitors.%20In%20addition%2C%20the%20recently%20elucidated%20structure%20of%20the%20glycosylated%20form%20of%20full-length%20ACE%20by%20cryo-electron%20microscopy%20%28cryo-EM%29%20has%20shed%20light%20on%20the%20mechanism%20of%20ACE%20dimerization%20and%20revealed%20continuous%20conformational%20changes%20which%20occur%20prior%20to%20ligand%20binding.%20In%20addition%20to%20these%20experimental%20techniques%2C%20computational%20approaches%20have%20also%20played%20a%20pivotal%20role%20in%20elucidating%20the%20structural%20basis%20for%20ACE%20inhibition.%20Molecular%20dynamics%20simulations%20and%20computational%20docking%20studies%20have%20provided%20atomic%20details%20of%20inhibitor%20binding%20kinetics%20and%20energetics%2C%20facilitating%20the%20rational%20design%20of%20novel%20ACE%20inhibitors%20with%20improved%20potency%20and%20selectivity.%20Furthermore%2C%20computational%20analysis%20of%20the%20motions%20observed%20by%20cryo-EM%20allowed%20the%20identification%20of%20allosteric%20binding%20sites%20on%20ACE.%20This%20affords%20new%20opportunities%20for%20the%20development%20of%20next-generation%20allosteric%20inhibitors%20with%20enhanced%20pharmacological%20properties.%20Overall%2C%20the%20insights%20highlighted%20in%20this%20review%20could%20enable%20the%20rational%20design%20of%20novel%20ACE%20inhibitors%20with%20improved%20efficacy%20and%20safety%20profiles%2C%20ultimately%20leading%20to%20better%20therapeutic%20outcomes%20for%20patients%20with%20hypertension%20and%20cardiovascular%20diseases.%22%2C%22date%22%3A%222024-08-05%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1042%5C%2FBSR20240130%22%2C%22ISSN%22%3A%220144-8463%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1042%5C%2FBSR20240130%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-11-09T13%3A49%3A10Z%22%7D%7D%2C%7B%22key%22%3A%228MEIYWVS%22%2C%22library%22%3A%7B%22id%22%3A1485676%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Oosthuizen%20et%20al.%22%2C%22parsedDate%22%3A%222024-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EOosthuizen%2C%20D.%2C%20Ganief%2C%20T.%20A.%2C%20Bernstein%2C%20K.%20E.%20%26amp%3B%20Sturrock%2C%20E.%20D.%20Proteomic%20Analysis%20of%20Human%20Macrophages%20Overexpressing%20Angiotensin-Converting%20Enzyme.%20%3Ci%3EInternational%20Journal%20of%20Molecular%20Sciences%3C%5C%2Fi%3E%20%3Cb%3E25%3C%5C%2Fb%3E%2C%207055%20%282024%29.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fbiophysicsworkshop.co.za%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D1485676%26amp%3Bitem_key%3D8MEIYWVS%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Proteomic%20Analysis%20of%20Human%20Macrophages%20Overexpressing%20Angiotensin-Converting%20Enzyme%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Delia%22%2C%22lastName%22%3A%22Oosthuizen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tariq%20A.%22%2C%22lastName%22%3A%22Ganief%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kenneth%20E.%22%2C%22lastName%22%3A%22Bernstein%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edward%20D.%22%2C%22lastName%22%3A%22Sturrock%22%7D%5D%2C%22abstractNote%22%3A%22Angiotensin%20converting%20enzyme%20%28ACE%29%20exerts%20strong%20modulation%20of%20myeloid%20cell%20function%20independently%20of%20its%20cardiovascular%20arm.%20The%20success%20of%20the%20ACE-overexpressing%20murine%20macrophage%20model%2C%20ACE%2010%5C%2F10%2C%20in%20treating%20microbial%20infections%20and%20cancer%20opens%20a%20new%20avenue%20into%20whether%20ACE%20overexpression%20in%20human%20macrophages%20shares%20these%20benefits.%20Additionally%2C%20as%20ACE%20inhibitors%20are%20a%20widely%20used%20antihypertensive%20medication%2C%20their%20impact%20on%20ACE%20expressing%20immune%20cells%20is%20of%20interest%20and%20currently%20understudied.%20In%20the%20present%20study%2C%20we%20utilized%20mass%20spectrometry%20to%20characterize%20and%20assess%20global%20proteomic%20changes%20in%20an%20ACE-overexpressing%20human%20THP-1%20cell%20line.%20Additionally%2C%20proteomic%20changes%20and%20cellular%20uptake%20following%20treatment%20with%20an%20ACE%20C-domain%20selective%20inhibitor%2C%20lisinopril%5Cu2013tryptophan%2C%20were%20also%20assessed.%20ACE%20activity%20was%20significantly%20reduced%20following%20inhibitor%20treatment%2C%20despite%20limited%20uptake%20within%20the%20cell%2C%20and%20both%20RNA%20processing%20and%20immune%20pathways%20were%20significantly%20dysregulated%20with%20treatment.%20Also%20present%20were%20upregulated%20energy%20and%20TCA%20cycle%20proteins%20and%20dysregulated%20cytokine%20and%20interleukin%20signaling%20proteins%20with%20ACE%20overexpression.%20A%20novel%2C%20functionally%20enriched%20immune%20pathway%20that%20appeared%20both%20with%20ACE%20overexpression%20and%20inhibitor%20treatment%20was%20neutrophil%20degranulation.%20ACE%20overexpression%20within%20human%20macrophages%20showed%20similarities%20with%20ACE%2010%5C%2F10%20murine%20macrophages%2C%20paving%20the%20way%20for%20mechanistic%20studies%20aimed%20at%20understanding%20the%20altered%20immune%20function.%22%2C%22date%22%3A%222024%5C%2F1%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.3390%5C%2Fijms25137055%22%2C%22ISSN%22%3A%221422-0067%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.mdpi.com%5C%2F1422-0067%5C%2F25%5C%2F13%5C%2F7055%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-11-09T13%3A52%3A18Z%22%7D%7D%2C%7B%22key%22%3A%22H66JZAPA%22%2C%22library%22%3A%7B%22id%22%3A1485676%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Gregory%20et%20al.%22%2C%22parsedDate%22%3A%222024%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EGregory%2C%20K.%20S.%2C%20Cozier%2C%20G.%20E.%2C%20Schwager%2C%20S.%20L.%20U.%2C%20Sturrock%2C%20E.%20D.%20%26amp%3B%20Acharya%2C%20K.%20R.%20Structural%20insights%20into%20the%20inhibitory%20mechanism%20of%20angiotensin-I-converting%20enzyme%20by%20the%20lactotripeptides%20IPP%20and%20VPP.%20%3Ci%3EFEBS%20Letters%3C%5C%2Fi%3E%20%3Cb%3E598%3C%5C%2Fb%3E%2C%20242%26%23×2013%3B251%20%282024%29.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fbiophysicsworkshop.co.za%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D1485676%26amp%3Bitem_key%3DH66JZAPA%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Structural%20insights%20into%20the%20inhibitory%20mechanism%20of%20angiotensin-I-converting%20enzyme%20by%20the%20lactotripeptides%20IPP%20and%20VPP%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kyle%20S.%22%2C%22lastName%22%3A%22Gregory%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gyles%20E.%22%2C%22lastName%22%3A%22Cozier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylva%20L.%20U.%22%2C%22lastName%22%3A%22Schwager%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edward%20D.%22%2C%22lastName%22%3A%22Sturrock%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%20Ravi%22%2C%22lastName%22%3A%22Acharya%22%7D%5D%2C%22abstractNote%22%3A%22Human%20somatic%20angiotensin-1-converting%20enzyme%20%28sACE%29%20is%20composed%20of%20a%20catalytic%20N-%28nACE%29%20and%20C-domain%20%28cACE%29%20of%20similar%20size%20with%20different%20substrate%20specificities.%20It%20is%20involved%20in%20the%20regulation%20of%20blood%20pressure%20by%20converting%20angiotensin%20I%20to%20the%20vasoconstrictor%20angiotensin%20II%20and%20has%20been%20a%20major%20focus%20in%20the%20development%20of%20therapeutics%20for%20hypertension.%20Bioactive%20peptides%20from%20various%20sources%2C%20including%20milk%2C%20have%20been%20identified%20as%20natural%20ACE%20inhibitors.%20We%20report%20the%20structural%20basis%20for%20the%20role%20of%20two%20lacototripeptides%2C%20Val-Pro-Pro%20and%20Ile-Pro-Pro%2C%20in%20domain-specific%20inhibition%20of%20ACE%20using%20X-ray%20crystallography%20and%20kinetic%20analysis.%20The%20lactotripeptides%20have%20preference%20for%20nACE%20due%20to%20altered%20polar%20interactions%20distal%20to%20the%20catalytic%20zinc%20ion.%20Elucidating%20the%20mechanism%20of%20binding%20and%20domain%20selectivity%20of%20these%20peptides%20also%20provides%20important%20insights%20into%20the%20functional%20roles%20of%20ACE.%22%2C%22date%22%3A%222024%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1002%5C%2F1873-3468.14768%22%2C%22ISSN%22%3A%221873-3468%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fonlinelibrary.wiley.com%5C%2Fdoi%5C%2Fabs%5C%2F10.1002%5C%2F1873-3468.14768%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-11-09T13%3A52%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22VSV6QEWF%22%2C%22library%22%3A%7B%22id%22%3A1485676%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22da%20Silva%20et%20al.%22%2C%22parsedDate%22%3A%222022-12-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3Eda%20Silva%2C%20R.%20L.%20%3Ci%3Eet%20al.%3C%5C%2Fi%3E%20Peptide%20inhibitors%20of%20angiotensin-I%20converting%20enzyme%20based%20on%20angiotensin%20%281%26%23×2013%3B7%29%20with%20selectivity%20for%20the%20C-terminal%20domain.%20%3Ci%3EBioorganic%20Chemistry%3C%5C%2Fi%3E%20%3Cb%3E129%3C%5C%2Fb%3E%2C%20106204%20%282022%29.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fbiophysicsworkshop.co.za%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D1485676%26amp%3Bitem_key%3DVSV6QEWF%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Peptide%20inhibitors%20of%20angiotensin-I%20converting%20enzyme%20based%20on%20angiotensin%20%281%5Cu20137%29%20with%20selectivity%20for%20the%20C-terminal%20domain%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rogerio%20L.%22%2C%22lastName%22%3A%22da%20Silva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Athanasios%22%2C%22lastName%22%3A%22Papakyriakou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adriana%20K.%22%2C%22lastName%22%3A%22Carmona%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Georgios%20A.%22%2C%22lastName%22%3A%22Spyroulias%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edward%20D.%22%2C%22lastName%22%3A%22Sturrock%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patr%5Cu00edcia%20A.%22%2C%22lastName%22%3A%22Bersanetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clovis%20R.%22%2C%22lastName%22%3A%22Nakaie%22%7D%5D%2C%22abstractNote%22%3A%22The%20renin-angiotensin%20system%20%28RAS%29%20is%20a%20key%20regulator%20of%20human%20arterial%20pressure.%20Several%20of%20its%20effects%20are%20modulated%20by%20angiotensin%20II%2C%20an%20octapeptide%20originating%20from%20the%20action%20of%20angiotensin-I%20converting%20enzyme%20%28ACE%29%20on%20the%20decapeptide%20angiotensin-I.%20ACE%20possess%20two%20active%20sites%20%28nACE%20and%20cACE%29%20that%20have%20their%20own%20kinetic%20and%20substrate%20specificities.%20ACE%20inhibitors%20are%20widely%20used%20as%20the%20first-line%20treatment%20for%20hypertension%20and%20other%20heart-related%20diseases%2C%20but%20because%20they%20inactivate%20both%20ACE%20domains%2C%20their%20use%20is%20associated%20with%20serious%20side%20effects.%20Thus%2C%20the%20search%20for%20domain-specific%20ACE%20inhibitors%20has%20been%20the%20focus%20of%20intense%20research.%20Angiotensin%20%281%5Cu20137%29%2C%20a%20peptide%20that%20also%20belongs%20to%20the%20RAS%2C%20acts%20as%20a%20substrate%20of%20nACE%20and%20an%20inhibitor%20of%20cACE.%20We%20have%20synthetized%2015%20derivatives%20of%20Ang%20%281%5Cu20137%29%2C%20sequentially%20removing%20the%20N-terminal%20amino%20acids%20and%20modifying%20peptides%20extremities%2C%20to%20find%20molecules%20with%20improved%20selectivity%20and%20inhibition%20properties.%20Ac-Ang%20%282%5Cu20137%29-NH2%20is%20a%20good%20ACE%20inhibitor%2C%20resistant%20to%20cleavage%20and%20with%20improved%20cACE%20selectivity.%20Molecular%20dynamics%20simulations%20provided%20a%20model%20for%20this%20peptide%5Cu2019s%20selectivity%2C%20due%20to%20Val3%20and%20Tyr4%20interactions%20with%20ACE%20subsites.%20Val3%20has%20an%20important%20interaction%20with%20the%20S3%20subsite%2C%20since%20its%20removal%20greatly%20reduced%20peptide-enzyme%20interactions.%20Taken%20together%2C%20our%20findings%20support%20ongoing%20studies%20using%20insights%20from%20the%20binding%20of%20Ac-Ang%20%282%5Cu20137%29-NH2%20to%20develop%20effective%20cACE%20inhibitors.%22%2C%22date%22%3A%222022-12-01%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.bioorg.2022.106204%22%2C%22ISSN%22%3A%220045-2068%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS0045206822006101%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-11-09T13%3A51%3A29Z%22%7D%7D%2C%7B%22key%22%3A%22ELR2NQWJ%22%2C%22library%22%3A%7B%22id%22%3A1485676%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Steckelings%20et%20al.%22%2C%22parsedDate%22%3A%222022-10%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ESteckelings%2C%20U.%20M.%20%3Ci%3Eet%20al.%3C%5C%2Fi%3E%20The%20Angiotensin%20AT2%20Receptor%3A%20From%20a%20Binding%20Site%20to%20a%20Novel%20Therapeutic%20Target.%20%3Ci%3EPharmacol%20Rev%3C%5C%2Fi%3E%20%3Cb%3E74%3C%5C%2Fb%3E%2C%201051%26%23×2013%3B1135%20%282022%29.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fbiophysicsworkshop.co.za%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D1485676%26amp%3Bitem_key%3DELR2NQWJ%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20Angiotensin%20AT2%20Receptor%3A%20From%20a%20Binding%20Site%20to%20a%20Novel%20Therapeutic%20Target%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22U.%20Muscha%22%2C%22lastName%22%3A%22Steckelings%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20E.%22%2C%22lastName%22%3A%22Widdop%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edward%20D.%22%2C%22lastName%22%3A%22Sturrock%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lizelle%22%2C%22lastName%22%3A%22Lubbe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tahir%22%2C%22lastName%22%3A%22Hussain%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elena%22%2C%22lastName%22%3A%22Kaschina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%22%2C%22lastName%22%3A%22Unger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anders%22%2C%22lastName%22%3A%22Hallberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20M.%22%2C%22lastName%22%3A%22Carey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Colin%22%2C%22lastName%22%3A%22Sumners%22%7D%5D%2C%22abstractNote%22%3A%22Discovered%20more%20than%2030%20years%20ago%2C%20the%20angiotensin%20AT2%20receptor%20%28AT2R%29%20has%20evolved%20from%20a%20binding%20site%20with%20unknown%20function%20to%20a%20firmly%20established%20major%20effector%20within%20the%20protective%20arm%20of%20the%20renin-angiotensin%20system%20%28RAS%29%20and%20a%20target%20for%20new%20drugs%20in%20development.%20The%20AT2R%20represents%20an%20endogenous%20protective%20mechanism%20that%20can%20be%20manipulated%20in%20the%20majority%20of%20preclinical%20models%20to%20alleviate%20lung%2C%20renal%2C%20cardiovascular%2C%20metabolic%2C%20cutaneous%2C%20and%20neural%20diseases%20as%20well%20as%20cancer.%20This%20article%20is%20a%20comprehensive%20review%20summarizing%20our%20current%20knowledge%20of%20the%20AT2R%2C%20from%20its%20discovery%20to%20its%20position%20within%20the%20RAS%20and%20its%20overall%20functions.%20This%20is%20followed%20by%20an%20in-depth%20look%20at%20the%20characteristics%20of%20the%20AT2R%2C%20including%20its%20structure%2C%20intracellular%20signaling%2C%20homo-%20and%20heterodimerization%2C%20and%20expression.%20AT2R-selective%20ligands%2C%20from%20endogenous%20peptides%20to%20synthetic%20peptides%20and%20nonpeptide%20molecules%20that%20are%20used%20as%20research%20tools%2C%20are%20discussed.%20Finally%2C%20we%20summarize%20the%20known%20physiological%20roles%20of%20the%20AT2R%20and%20its%20abundant%20protective%20effects%20in%20multiple%20experimental%20disease%20models%20and%20expound%20on%20AT2R%20ligands%20that%20are%20undergoing%20development%20for%20clinical%20use.%20The%20present%20review%20highlights%20the%20controversial%20aspects%20and%20gaps%20in%20our%20knowledge%20of%20this%20receptor%20and%20illuminates%20future%20perspectives%20for%20AT2R%20research.%20SIGNIFICANCE%20STATEMENT%3A%20The%20angiotensin%20AT2%20receptor%20%28AT2R%29%20is%20now%20regarded%20as%20a%20fully%20functional%20and%20important%20component%20of%20the%20renin-angiotensin%20system%2C%20with%20the%20potential%20of%20exerting%20protective%20actions%20in%20a%20variety%20of%20diseases.%20This%20review%20provides%20an%20in-depth%20view%20of%20the%20AT2R%2C%20which%20has%20progressed%20from%20being%20an%20enigma%20to%20becoming%20a%20therapeutic%20target.%22%2C%22date%22%3A%222022-10%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1124%5C%2Fpharmrev.120.000281%22%2C%22ISSN%22%3A%221521-0081%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-11-09T13%3A50%3A46Z%22%7D%7D%2C%7B%22key%22%3A%226K8PEHIE%22%2C%22library%22%3A%7B%22id%22%3A1485676%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lubbe%20et%20al.%22%2C%22parsedDate%22%3A%222022-08-16%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ELubbe%2C%20L.%2C%20Sewell%2C%20B.%20T.%2C%20Woodward%2C%20J.%20D.%20%26amp%3B%20Sturrock%2C%20E.%20D.%20Cryo%26%23×2010%3BEM%20reveals%20mechanisms%20of%20angiotensin%20I%26%23×2010%3Bconverting%20enzyme%20allostery%20and%20dimerization.%20%3Ci%3EThe%20EMBO%20Journal%3C%5C%2Fi%3E%20%3Cb%3E41%3C%5C%2Fb%3E%2C%20e110550%20%282022%29.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fbiophysicsworkshop.co.za%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D1485676%26amp%3Bitem_key%3D6K8PEHIE%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Cryo%5Cu2010EM%20reveals%20mechanisms%20of%20angiotensin%20I%5Cu2010converting%20enzyme%20allostery%20and%20dimerization%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lizelle%22%2C%22lastName%22%3A%22Lubbe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20Trevor%22%2C%22lastName%22%3A%22Sewell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%20D%22%2C%22lastName%22%3A%22Woodward%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edward%20D%22%2C%22lastName%22%3A%22Sturrock%22%7D%5D%2C%22abstractNote%22%3A%22Hypertension%20%28high%20blood%20pressure%29%20is%20a%20major%20risk%20factor%20for%20cardiovascular%20disease%2C%20which%20is%20the%20leading%20cause%20of%20death%20worldwide.%20The%20somatic%20isoform%20of%20angiotensin%20I%5Cu2010converting%20enzyme%20%28sACE%29%20plays%20a%20critical%20role%20in%20blood%20pressure%20regulation%2C%20and%20ACE%20inhibitors%20are%20thus%20widely%20used%20to%20treat%20hypertension%20and%20cardiovascular%20disease.%20Our%20current%20understanding%20of%20sACE%20structure%2C%20dynamics%2C%20function%2C%20and%20inhibition%20has%20been%20limited%20because%20truncated%2C%20minimally%20glycosylated%20forms%20of%20sACE%20are%20typically%20used%20for%20X%5Cu2010ray%20crystallography%20and%20molecular%20dynamics%20simulations.%20Here%2C%20we%20report%20the%20first%20cryo%5Cu2010EM%20structures%20of%20full%5Cu2010length%2C%20glycosylated%2C%20soluble%20sACE%20%28sACES1211%29.%20Both%20monomeric%20and%20dimeric%20forms%20of%20the%20highly%20flexible%20apo%20enzyme%20were%20reconstructed%20from%20a%20single%20dataset.%20The%20N%5Cu2010%20and%20C%5Cu2010terminal%20domains%20of%20monomeric%20sACES1211%20were%20resolved%20at%203.7%20and%204.1%5Cu2009%5Cu00c5%2C%20respectively%2C%20while%20the%20interacting%20N%5Cu2010terminal%20domains%20responsible%20for%20dimer%20formation%20were%20resolved%20at%203.8%5Cu2009%5Cu00c5.%20Mechanisms%20are%20proposed%20for%20intradomain%20hinging%2C%20cooperativity%2C%20and%20homodimerization.%20Furthermore%2C%20the%20observation%20that%20both%20domains%20were%20in%20the%20open%20conformation%20has%20implications%20for%20the%20design%20of%20sACE%20modulators.%22%2C%22date%22%3A%222022-08-16%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.15252%5C%2Fembj.2021110550%22%2C%22ISSN%22%3A%220261-4189%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.embopress.org%5C%2Fdoi%5C%2Ffull%5C%2F10.15252%5C%2Fembj.2021110550%22%2C%22collections%22%3A%5B%22EENXQ3XN%22%5D%2C%22dateModified%22%3A%222024-11-03T20%3A34%3A45Z%22%7D%7D%2C%7B%22key%22%3A%22VUAZPUX3%22%2C%22library%22%3A%7B%22id%22%3A1485676%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cozier%20et%20al.%22%2C%22parsedDate%22%3A%222022%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECozier%2C%20G.%20E.%20%3Ci%3Eet%20al.%3C%5C%2Fi%3E%20Structural%20basis%20for%20the%20inhibition%20of%20human%20angiotensin-1%20converting%20enzyme%20by%20fosinoprilat.%20%3Ci%3EThe%20FEBS%20Journal%3C%5C%2Fi%3E%20%3Cb%3E289%3C%5C%2Fb%3E%2C%206659%26%23×2013%3B6671%20%282022%29.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fbiophysicsworkshop.co.za%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D1485676%26amp%3Bitem_key%3DVUAZPUX3%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Structural%20basis%20for%20the%20inhibition%20of%20human%20angiotensin-1%20converting%20enzyme%20by%20fosinoprilat%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gyles%20E.%22%2C%22lastName%22%3A%22Cozier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emma%20C.%22%2C%22lastName%22%3A%22Newby%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylva%20L.%20U.%22%2C%22lastName%22%3A%22Schwager%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%20Elwyn%22%2C%22lastName%22%3A%22Isaac%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edward%20D.%22%2C%22lastName%22%3A%22Sturrock%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%20Ravi%22%2C%22lastName%22%3A%22Acharya%22%7D%5D%2C%22abstractNote%22%3A%22Human%20angiotensin%20I-converting%20enzyme%20%28ACE%29%20has%20two%20isoforms%2C%20somatic%20ACE%20%28sACE%29%20and%20testis%20ACE%20%28tACE%29.%20The%20functions%20of%20sACE%20are%20widespread%2C%20with%20its%20involvement%20in%20blood%20pressure%20regulation%20most%20extensively%20studied.%20sACE%20is%20composed%20of%20an%20N-domain%20%28nACE%29%20and%20a%20C-domain%20%28cACE%29%2C%20both%20catalytically%20active%20but%20have%20significant%20structural%20differences%2C%20resulting%20in%20different%20substrate%20specificities.%20Even%20though%20ACE%20inhibitors%20are%20used%20clinically%2C%20they%20need%20much%20improvement%20because%20of%20serious%20side%20effects%20seen%20in%20patients%20%28%2025%5Cu201330%25%29%20with%20long-term%20treatment%20due%20to%20nonselective%20inhibition%20of%20nACE%20and%20cACE.%20Investigation%20into%20the%20distinguishing%20structural%20features%20of%20each%20domain%20is%20therefore%20of%20vital%20importance%20for%20the%20development%20of%20domain-specific%20inhibitors%20with%20minimal%20side%20effects.%20Here%2C%20we%20report%20kinetic%20data%20and%20high-resolution%20crystal%20structures%20of%20both%20nACE%20%281.75%20%5Cu00c5%29%20and%20cACE%20%281.85%20%5Cu00c5%29%20in%20complex%20with%20fosinoprilat%2C%20a%20clinically%20used%20inhibitor.%20These%20structures%20allowed%20detailed%20analysis%20of%20the%20molecular%20features%20conferring%20domain%20selectivity%20by%20fosinoprilat.%20Particularly%2C%20altered%20hydrophobic%20interactions%20were%20observed%20to%20be%20a%20contributing%20factor.%20These%20experimental%20data%20contribute%20to%20improved%20understanding%20of%20the%20structural%20features%20that%20dictate%20ACE%20inhibitor%20domain%20selectivity%2C%20allowing%20further%20progress%20towards%20designing%20novel%202nd-generation%20domain-specific%20potent%20ACE%20inhibitors%20suitable%20for%20clinical%20administration%2C%20with%20a%20variety%20of%20potential%20future%20therapeutic%20benefits.%20Database%20The%20atomic%20coordinates%20and%20structure%20factors%20for%20nACE-fosinoprilat%20and%20cACE-fosinoprilat%20structures%20have%20been%20deposited%20with%20codes%207Z6Z%20and%207Z70%2C%20respectively%2C%20in%20the%20RCSB%20Protein%20Data%20Bank%2C%20www.pdb.org.%22%2C%22date%22%3A%222022%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1111%5C%2Ffebs.16543%22%2C%22ISSN%22%3A%221742-4658%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fonlinelibrary.wiley.com%5C%2Fdoi%5C%2Fabs%5C%2F10.1111%5C%2Ffebs.16543%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-11-09T13%3A53%3A37Z%22%7D%7D%5D%7D
1.
Acharya, K. R., Gregory, K. S. & Sturrock, E. D. Advances in the structural basis for angiotensin-1 converting enzyme (ACE) inhibitors. Bioscience Reports 44, BSR20240130 (2024). Cite
1.
Oosthuizen, D., Ganief, T. A., Bernstein, K. E. & Sturrock, E. D. Proteomic Analysis of Human Macrophages Overexpressing Angiotensin-Converting Enzyme. International Journal of Molecular Sciences 25, 7055 (2024). Cite
1.
Gregory, K. S., Cozier, G. E., Schwager, S. L. U., Sturrock, E. D. & Acharya, K. R. Structural insights into the inhibitory mechanism of angiotensin-I-converting enzyme by the lactotripeptides IPP and VPP. FEBS Letters 598, 242–251 (2024). Cite
1.
da Silva, R. L. et al. Peptide inhibitors of angiotensin-I converting enzyme based on angiotensin (1–7) with selectivity for the C-terminal domain. Bioorganic Chemistry 129, 106204 (2022). Cite
1.
Steckelings, U. M. et al. The Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic Target. Pharmacol Rev 74, 1051–1135 (2022). Cite
1.
Lubbe, L., Sewell, B. T., Woodward, J. D. & Sturrock, E. D. Cryo‐EM reveals mechanisms of angiotensin I‐converting enzyme allostery and dimerization. The EMBO Journal 41, e110550 (2022). Cite
1.
Cozier, G. E. et al. Structural basis for the inhibition of human angiotensin-1 converting enzyme by fosinoprilat. The FEBS Journal 289, 6659–6671 (2022). Cite